The Impact of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Metabolic Rate in Drosophila melanogaster
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251810103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Denise Vecchie' und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Drosophila melanogaster, Angiotensin-Converting Enzyme Inhibitors, Lisinopril, Drosophila Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Evidence suggests that angiotensin-converting enzyme inhibitors (ACEIs) may increase metabolic rate by promoting thermogenesis, potentially through enhanced fat oxidation and improved insulin. More research is, however, needed to understand this intricate process. In this study, we used 22 lines from the Drosophila Genetic Reference Panel to assess the metabolic rate of virgin female and male flies that were either fed a standard medium or received lisinopril for one week or five weeks. We demonstrated that lisinopril affects the whole-body metabolic rate in Drosophila melanogaster in a genotype-dependent manner. However, the effects of genotypes are highly context-dependent, being influenced by sex and age. Our findings also suggest that lisinopril may increase the Drosophila metabolic rate via the accumulation of a bradykinin-like peptide, which, in turn, enhances cold tolerance by upregulating Ucp4b and Ucp4c genes. Finally, we showed that knocking down Ance, the ortholog of mammalian ACE in Malpighian/renal tubules and the nervous system, leads to opposite changes in metabolic rate, and that the effect of lisinopril depends on Ance in these systems, but in a sex- and age-specific manner. In conclusion, our results regarding D. melanogaster support existing evidence of a connection between ACEI drugs and metabolic rate while offering new insights into this relationship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Department of Pharmaceutical, Social and Administrative Sciences, Samford University, Birmingham, AL 35229, USA.
- Department of Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
ORCID-Profile: Jesse Perry, Patricia Jumbo-Lucioni, Maria De Luca
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- National Institute on Aging
- National Institutes of Health
Zitieren
APA
Vecchie', D., Wolter, J. M., Perry, J., Jumbo-Lucioni, P., & De Luca, M. (2024). The Impact of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Metabolic Rate in Drosophila melanogaster. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810103
Vancouver
Vecchie' D, Wolter JM, Perry J, Jumbo-Lucioni P, De Luca M. The Impact of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Metabolic Rate in Drosophila melanogaster. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810103
BibTeX
@article{Vecchie2024,
author = {Vecchie', Denise and Wolter, Julia M and Perry, Jesse and Jumbo-Lucioni, Patricia and De Luca, Maria},
title = {The Impact of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Metabolic Rate in Drosophila melanogaster},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251810103}
}
EUVIMED